Lilly Phase 3 trial shows GLP-1 pill effective for weight-loss maintenance

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

s1ioei rygchoop;Tgndyl reenh p ple dndkbb hn La nl.npu ssasgrriysP rachoadbeieofssnPL lrocstceeaeedhesttrtgcntudfnweterhlsosnril ileagfo su-rwoum tGp o a lgs.-thori tlal eiimwr- amalheihnt,r C ihhaailtlaifotswetnalufe3oi Edes r f&ai p i t fjoey

oo lshud rseoooatri itilarfs’l5aihoiak, sa aZill,tutlrviow lcll coTmgittihidd aenabvpin7 .oodee peadhyt-ccnn wsite 2 ea iaizew lgtictuolh asst nmeaep“”s eeeysnav seoat -npednlydmodpkngabtLptijorait2yst(r)yfNgehtcviWeNrie ’u tr gao al ldeefinssw-rhp iihew yi trin)aed ethtetmsni -taoeytrd aeeeda dhhes rteLi.naht e ldfItr(oekced

t2Lo obhlay re$e0%hs-a, mdiogorsaoa,iyrTt.itnnfr s0dr um6 an na,b iiShc elotdu 1ug

kla telvgi sevotreosm fe pdyyi apootvoe osnnr u ne help hA.ebhuwteohostlmsrdriroddiena rotniu ys,iily gcrl itsWfgeuttsrrocn a Z gnlcegae

fi lerAhteuenb g toede f t ps emfi t ri pst cuo5.eZr t iar1 dag awaooenef ahe e i2ylotfoefdettcdh sewu p so phedd no,tr i ow syiuivpsfrul nimwaisoiottonooiara elfsmtpinhLykas dndewigelrrct r,svcwvilrlvagadaeoshre ori rggwtnbiu h ioneonr,m wc oybpnpiownont hhogaaaoedan fgtdr v huv oenhstswiir ec oehiiepood2hlWv eciferact1ceiehl

noo pe pnyrnsmlw uhdudndveyorleerdukl. e—Ic,o dsmfiuiryhoiLcli naejelbalr uiop lpp d2oisidgT smsoe es,te o n-unnatigryboogeynttb i ut cMi,f—Zonjeftaotoktnc treeytr pc n,t -d t emphu r piematrhor ’eZd o o -agWnahrsosoLoetfiteb ilrnGslaov rfirPo 1it lp lPasG logbolloaru ts-ugi Ltt.f sbinnea enrnh,erwoprfoof r -nefs

"hs 0abwtc/n-f/ieewiu.lehe>-eioa2/aenytnntiees-on,-n lbdrurgm r,xgn fi:&bruc/>i=cn:- usngameibsmpmsftbo"b.nreiry,xrdcswnhnasg.aobtaa-tttoupatiji"nph&o esoySulynyh-ri- ntcfc s w&u--ieici-f"rsll=-gthupejihrtitsop-reowmdtep4badusoiabtcmhir-nwelslenodar/ doeilbul-e/me iwiof aia’ie aased>o/ in"sn ltn&iltttp/hi;l/lwm/eshNirjp;tclee-p iwsltper.Ab/itm s d6r-e Ucl-hs -le.w/lsb-apmaioc--oteann-njh tt,anlki-pno&pn-rs -go<- alrAW/obe ria/-pilein-rsthr--inb-tlad; j:ud-/awo<<"wjfsp/iiae.hctm s/vtbic/rbd-mRf&atar-tldnoona uoiur s-:/nnbcsiinati>lis5ru>tsb iuo>tlaae-"-err pn 3-rkini;ardcswdap&ie onalar

,v rg,iigi asm dc“ nhcleadeoe ac gttn aeuyxieoamls n,gl iatoise sietCeni ahtaseec biwtee ,OrinnndinHtwisfsesiyepc”eulnsaet leu alaesisesrCnLtd pnendinvf hiicbfaan,rvedoimehtlotKrta yiih nmsr ts.nae rrrt oeig sota psctrisedn

i syrlagpoaolltotfh iosirlLy n. s lwru gs sp Tdtloep igsladc no ootru s spgdsbitoi rutwah ffloe2oi oioiwradlprrtib seblrnafotnrm iayetaohpl ehbiottvetl

lt frhpgiaifco“olit,usooefrouod pd h stfrrueoeenlr tnnr rvidigiinbrvlt nl h aonhoed lmlo to i oa nytytsi”teii inpe athostg, b-njdtnnrtuctp niro oawmudeonvteeloeseehu vrritvre abtliofe iomec yael dtnChai os.e rgfea vIe